Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105906578B details platinum-catalyzed oxazole synthesis. Offers high yield and scalable process for pharmaceutical intermediate supply chains.
Novel resolution method for cis-chiral intermediate. Reduces cost and improves scalability for pharmaceutical manufacturing supply chains.
Patent CN101346360A reveals a streamlined route for thrombin inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN116240249B reveals acidic enzymatic hydrolysis for high-purity bases. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102584677B details a green Gliclazide route. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN117568294A reveals P450 mutant for S-halohydrins. Offers green synthesis and supply chain stability for pharma intermediates.
Patent CN104540807B details a novel synthesis for PDE10 inhibitor intermediates offering enhanced selectivity and scalable manufacturing capabilities for global supply chains.
Novel three-step asymmetric synthesis route for high-purity (S)-rivastigmine intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel synthesis of bevacizidine acid avoids ultra-low temperatures. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel rearrangement and protection strategy for hydrocortisone production offering improved yield and milder conditions for pharmaceutical manufacturers.
Novel two-step route for Remdesivir intermediate CN111205294A. Enhanced chiral purity, reduced cost, scalable manufacturing for global pharma supply chains.
Patent CN105837530B reveals cost-effective pleuromutilin synthesis. Discover supply chain advantages and high-purity manufacturing capabilities for global pharma.
Discover novel fluorene ring compounds for efficient peptide synthesis. Enhance purity and reduce costs in pharmaceutical intermediate manufacturing with scalable liquid phase carriers.
Patent CN114524751B reveals high-yield aryl nitrile synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
CN117305198A reveals high-efficiency recombinant bacterium method for L-Dopa. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104725256A details a novel synthesis route for biphenyl alanine derivatives offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for global buyers.
Patent CN102766081A reveals a green, solvent-free route for bis-indolylmethane derivatives using reusable ionic liquids, offering significant cost and supply chain advantages.
Novel Lewis acid catalyzed route for Everolimus reduces steps and improves purity. Ideal for pharmaceutical intermediates supply chain cost reduction and scale-up.
Novel oxygen-introduction method reduces Impurity A below 0.10% effectively. Cost-effective Irbesartan intermediate manufacturing process ensures enhanced supply chain reliability for global pharmaceutical partners.
Patent CN114380748A details a continuous flow synthesis for Pazopanib intermediates, offering enhanced safety, purity, and scalable manufacturing capabilities for global supply chains.